For years, a pharma study ended with a deck and a folder. ZoomRx is betting that its 60,000-plus-member panel, 700 million benchmark data points and new AI products can turn those forgotten files into a living commercial memory.
Medical-device teams were drowning in data but still waiting weeks for answers. Axiom Health built the co-pilot it wished existed - and its 2025 sale to Sorcero shows where vertical AI gets valuable.